According to GWAS [216], polymorphisms in the MINK1 gene have been detected in many more conditions, including epilepsy, amyotrophic lateral sclerosis, bipolar disorder, astigmatism, breast and prostatic neoplasms, Crohn’s disease, insulin resistance, Parkinson’s disease, Hodgkin disease, schizophrenia, or type II diabetes. This evidence concerns the gene MINK1 and bipolar disorder.